Experimental models of neuromyelitis optica: current status, challenges and future directions.
about
Variable sensitivity to complement-dependent cytotoxicity in murine models of neuromyelitis optica.Neuroinflammation.Astrocytic Interleukin-15 Reduces Pathology of Neuromyelitis Optica in Mice.Combination Treatment of C16 Peptide and Angiopoietin-1 Alleviates Neuromyelitis Optica in an Experimental Model.
P2860
Experimental models of neuromyelitis optica: current status, challenges and future directions.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Experimental models of neuromy ...... llenges and future directions.
@en
type
label
Experimental models of neuromy ...... llenges and future directions.
@en
prefLabel
Experimental models of neuromy ...... llenges and future directions.
@en
P2860
P1476
Experimental models of neuromy ...... llenges and future directions.
@en
P2093
P2860
P2888
P304
P356
10.1007/S12264-015-1552-6
P577
2015-06-24T00:00:00Z